Sex and gender differences and pharmacovigilance: a knot still to be untied

Sex and gender differences and pharmacovigilance: a knot still to be untied

Bibliographic Details
Main Authors:	Liberata Sportiello, Annalisa Capuano
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Pharmacology
Subjects:	adverse drug reaction sex gender differences pharmacology pharmacovigilance
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1397291/full

Similar Items

A Sex- and Gender-Based Analysis of Adverse Drug Reactions: A Scoping Review of Pharmacovigilance Databases
by: Andreea C. Brabete, et al.
Published: (2022-02-01)

Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System
by: Cristina Scavone, et al.
Published: (2020-04-01)

Gender Differences in Adverse Drug Reactions Among Adult Patients Reported to the Iraqi Pharmacovigilance Center
by: Areej Atheer Alsaedi, et al.
Published: (2021-12-01)

It is the time to change the paradigms of pregnant and breastfeeding women in clinical research!
by: Liberata Sportiello, et al.
Published: (2023-02-01)

Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance
by: Rosanna Ruggiero, et al.
Published: (2022-09-01)

Cinemeducation: a rigorous method to teach pharmacovigilance procedures in clinical pharmacology
by: Irene Cambra-Badii, et al.
Published: (2020-12-01)

Oro-Dental Pharmacovigilance in the Digital Age: Promoting Knowledge, Awareness, and Practice in Italy through a Smart Combined System—A Conference at the 30th National Congress of the Italian College of University Professors of Dental Disciplines
by: Gaetano La Mantia, et al.
Published: (2023-09-01)

Pharmacovigilance: Scope for a dermatologist
by: Bhanu Prakash, et al.
Published: (2011-01-01)

Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization’s Reporting? A Pharmacovigilance Study in Southern Italy
by: Cristina Scavone, et al.
Published: (2018-09-01)

Pharmacovigilance: Empowering healthcare professionals
by: Mugoša Snežana S., et al.
Published: (2015-01-01)

Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database
by: Rosanna Ruggiero, et al.
Published: (2024-01-01)

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
by: Alan O. Vázquez-Alvarez, et al.
Published: (2017-12-01)

Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia
by: E. N. Tkhoseva, et al.
Published: (2022-06-01)

Evaluation of Pharmacovigilance System in Iran
by: Malahat Khalili, et al.
Published: (2022-07-01)

DEBATABLE PROBLEMS OF PHARMACOVIGILANCE
by: Yu. V. Muravyev, et al.
Published: (2018-03-01)

IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
by: Yu. V. Muravyev
Published: (2017-09-01)

National strategy for the integration of pharmacovigilance in the Moroccan TB Control Program
by: Driss Soussi Tanani, et al.
Published: (2017-01-01)

Pharmacovigilance in India
by: Sarita Mulkalwar, et al.
Published: (2013-01-01)

SIGNIFICANCE OF PHARMACOVIGILANCE AND ITS CLINICAL IMPLICATIONS
by: Susanta Kumar Bandyopadhyay, et al.
Published: (2016-12-01)

Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
by: Rosanna Ruggiero, et al.
Published: (2020-06-01)

Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study
by: Kishor A Bansod, et al.
Published: (2020-01-01)

Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?
by: Pramod Kumar Sharma, et al.
Published: (2016-01-01)

Current status and future prospects of pharmacovigilance in Pakistan
by: Rabia Hussain, et al.
Published: (2019-12-01)

Assessment of community pharmacists concerning pharmacovigilance in Iraq
by: Muhannad R. M. Salih, et al.
Published: (2016-01-01)

Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study
by: Annamaria Mascolo, et al.
Published: (2022-10-01)

The pharmacovigilance of psychoactive medications in Brazil
by: Elisaldo Luiz de Araújo Carlini, et al.
Published: (2003-10-01)

ROLE OF COMMUNITY PHARMACIST IN PHARMACOVIGILENCE
by: Nayab Farooq, et al.
Published: (2019-09-01)

Challenges and experiences in establishing a zonal pharmacovigilance centre at Bangabandhu Sheikh Mujib Medical University: A 10-month journey
by: Elora Sharmin, et al.
Published: (2024-03-01)

Pharmacovigilance Programme of India
by: Duvvuru Ashok Kumar, et al.
Published: (2015-01-01)

Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL
by: Annamaria Mascolo, et al.
Published: (2023-08-01)

Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database
by: Liberata Sportiello, et al.
Published: (2023-11-01)

Knowledge, attitude, and practice study of pharmacovigilance in a dental teaching institute in Western India
by: Rashmi Venkatesh, et al.
Published: (2024-10-01)

A pharmacovigilance study on patients of bronchial asthma in a teaching hospital
by: A N Jamali, et al.
Published: (2010-01-01)

Pharmacovigilance Activities in Maulana Azad Medical College and Associated Hospitals: A Step towards Patient Safety
by: Vandana Roy, et al.
Published: (2023-01-01)

Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey
by: Zakir Khan, M.Phil, et al.
Published: (2022-04-01)

Assessment of knowledge, practices, and barriers to pharmacovigilance among nurses at a teaching hospital, Ghana: a cross‑sectional study
by: Paa Kofi Tawiah Adu-Gyamfi, et al.
Published: (2022-08-01)

Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025
by: V. I. Petrov
Published: (2025-01-01)

Perspective of undergraduate health-care students on adverse drug reaction and pharmacovigilance
by: Ahmed Atia, et al.
Published: (2023-01-01)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
by: Hadi MA, et al.
Published: (2017-03-01)

Comparative evaluation of pharmacovigilance regulation of the United States, United Kingdom, Canada, India and the need for global harmonized practices
by: Mohit Hans, et al.
Published: (2018-01-01)